Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren for hypertension associated with obstructive sleep apnea syndrome
ChiCTR1900028215Phase 4Recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aliskiren in hypertension (HTN), sponsored by Beijing An Zhen Hospital. Primary endpoints: 24-hour ambulatory blood pressure measurement at week 8, Clinic blood pressure at week 8 and 1 more. Started Dec 2019; status: recruiting.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR1900028215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028215.